Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sudden cardiac death in nonischemic cardiomyopathy.
Kadakia RS, Link MS, Dominic P, Morin DP. Kadakia RS, et al. Among authors: link ms. Prog Cardiovasc Dis. 2019 May-Jun;62(3):235-241. doi: 10.1016/j.pcad.2019.05.002. Epub 2019 May 8. Prog Cardiovasc Dis. 2019. PMID: 31075279 Review.
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Maron BJ, et al. Among authors: link ms. JAMA. 2007 Jul 25;298(4):405-12. doi: 10.1001/jama.298.4.405. JAMA. 2007. PMID: 17652294
Sudden cardiac death in athletes.
Link MS, Mark Estes NA 3rd. Link MS, et al. Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):44-57. doi: 10.1016/j.pcad.2007.10.002. Prog Cardiovasc Dis. 2008. PMID: 18634917 Review.
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Maron BJ, et al. Among authors: link ms. J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037. J Am Coll Cardiol. 2013. PMID: 23500286 Free article.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators. Wiviott SD, et al. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.
Targeted temperature management for cardiac arrest.
Mody P, Kulkarni N, Khera R, Link MS. Mody P, et al. Among authors: link ms. Prog Cardiovasc Dis. 2019 May-Jun;62(3):272-278. doi: 10.1016/j.pcad.2019.05.007. Epub 2019 May 10. Prog Cardiovasc Dis. 2019. PMID: 31078561 Review.
339 results